Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
cidofovir
Ultragenyx UK Limited
Cytomegalovirus Retinitis
1 trial -
coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
emtricitabine/tenofovir alafenamide
United Therapeutics Europe Ltd
Acceptability of Health Care
1 trial -
low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
Sinovac Research and Development Co.,
Hand, Foot and Mouth Disease
1 trial -
middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Norovirus Infections
1 trial -
oncolytic adenovirus expressing GMCSF
CG Oncology
Bladder Cancer
1 trial -
ribavirin (RBV)
Boehringer Ingelheim
Hepatitis C
1 trial -
split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Influenza
2 trials -
telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C Virus Infection
1 trial -
telaprevir or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
zelicapavir
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
100U inactivated Enterovirus Type 71 Vaccine
Sinovac Research and Development Co.,
Hand-foot-mouth Disease
1 trial -
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HPV Infection
1 trial -
A Phase 1 First-in-Human Study of the Safety and Effects of VIR-5818 Alone or with Pembrolizumab in Participants with Advanced or Metastatic HER2-Expressing Cancers
Vir Biotechnology
Participants with Locally Advanced or Metastatic HER2-Expressing Cancers
1 trial -
A Randomized, Blinded, Placebo-Controlled Dose-Ranging Phase 1b Study of the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects with Chronic Hepatitis B Virus Infection
ASSEMBLY BIOSCIENCES, INC.
chronic hepatitis B virus infection (cHBV)
1 trial -
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)
Hoffmann-La Roche
Diffuse large B-cell lymphoma (DLBCL), Grade 3B follicular lymphoma, High grade B-cell lymphoma (HGBL), Epstein-Barr virusβpositive DLBCL
1 trial -
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults
Pfizer Australia Pty Ltd
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1 trial -
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of the Study Medicine Called Ibuzatrelvir.
Pfizer Australia Pty Ltd
Coronavirus disease 2019
1 trial -
A clinical study of MK-3508 in healthy people (MK-3508-006)
Merck Sharp and Dohme
Respiratory syncytial virus infection
1 trial -
A clinical study of the V540A vaccine in healthy adults (V540A-001)
Merck Sharp and Dohme
Human Papilloma virus
1 trial -
A clinical study of the V540C vaccine in healthy adults (V540C-003)
Merck Sharp and Dohme
Human Papilloma virus
1 trial -
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma
Blue Earth Diagnostics Ireland Ltd
Treatment of human papilloma virus (HPV) associated infections and cancers
1 trial -
A study of different dose levels of FluBHPVE6E7 or placebo in women infected with the virus Human Papilloma Type 16 (HPV 16).
Blue Earth Diagnostics Ireland Ltd
Treatment of human papilloma virus (HPV) associated infections, precancers and cancers
1 trial -
A study on the safety of and immune response to different doses of an mRNA vaccine against RSV in healthy adults.
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources